BeyondSpring Inc. Ordinary Shares

BYSINASDAQUSD
1.71 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
1.69
0.02 (1.17%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
1.69
0.02 (1.17%)
🔴Market: CLOSED
Open?$1.65
High?$1.73
Low?$1.60
Prev. Close?$1.71
Volume?24.0K
Avg. Volume?21.3K
VWAP?$1.66
Rel. Volume?1.12x
Bid / Ask
Bid?$1.29 × 100
Ask?$1.95 × 100
Spread?$0.66
Midpoint?$1.62
Valuation & Ratios
Market Cap?70.3M
Shares Out?41.1M
Float?28.8M
Float %?71.4%
P/E Ratio?N/A
P/B Ratio?-2.04
EPS?-$0.19
Dividend?0.00%
Ex-Dividend?N/A

Shares of BeyondSpring Inc. Ordinary Shares (BYSI) are trading at $1.71. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (22.2%) and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
Employees
44
Market Cap
70.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2017-03-09
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR
FLORHAM PARK, NJ 07932
Phone: 646-528-4184
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
35
Short Sent.?
28
Piotroski F-Score?0/9Weak
Altman Z-Score?-31.43Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?7.59%Elevated
Short Interest?2.2M
Days to Cover?135.3
Free Float28.8M
Avg Daily Volume16.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.16Strong
Quick Ratio?2.16Strong
Cash Ratio?0.64Adequate
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
S&P
97
-2.04CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
Peers
50
S&P
70
22.2%STRONG
ROA?
S&P
3
-41.5%WEAK
Cash Flow & Enterprise
FCF?$-18848000
Enterprise Value?$66.3M
Fundamentals ratios updated end of day